Knowledge gaps in extracorporeal blood purification: what would be required for its successful application in septic shock?

作者
Sascha David,Thomas Rimmelé,Michael Joannidis,Massimo Girardis,Peter Pickkers,Nathan D. Nielsen,Alix Buhlmann,Zsolt Molnár,Marlies Ostermann,Jan Thomas Kielstein,Pedro David Wendel‐Garcia,Christian Bode,Klaus Stahl
出处
期刊:Intensive Care Medicine Experimental [Springer Nature]
卷期号:13 (1): 118-118 被引量:11
标识
DOI:10.1186/s40635-025-00819-8
摘要

Sepsis remains a leading cause of death worldwide, characterized by a dysregulated host response to infection that results in organ dysfunction. Extracorporeal blood purification (EBP) therapies traditionally aim to remove circulating mediators involved in this pathological response, although novel technologies that can remove cells and even living pathogens have recently been developed. Despite their growing clinical use, robust evidence supporting EBP in septic shock as an adjuvant therapy is lacking, and several knowledge gaps hinder their effective and safe application. This narrative review critically examines these gaps from both mechanistic and clinical perspectives. Key issues include the dynamic and compartmentalized nature of the immune response, the unclear roles of specific cytokines, and the potential removal of protective anti-inflammatory mediators. Broad-spectrum adsorption may induce unintended immunomodulatory effects, including desorption and altered leukocyte trafficking. Selective approaches, such as endotoxin removal with polymyxin B hemoadsorption, face challenges related to dose, patient stratification, and the limitations of endotoxin activity assays. Therapeutic plasma exchange offers the potential to restore homeostasis but raises questions regarding optimal regimens, replacement fluids, and the risk of unintended drug clearance. The heterogeneity of trial designs, insufficient patient phenotyping, and variability in treatment protocols have led to inconclusive or conflicting clinical outcomes, including some trials suggesting potential harm. This review underscores the need for better mechanistic understanding, real-time immune monitoring, and ideally targeted clinical trial designs to define which patients might benefit from EBP and when. Ultimately, the path to effective application of EBP in sepsis lies in individualized therapy guided by immune profiling, biomarker-driven stratification, and rigorous evaluation in high-quality randomized controlled trials.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
灯座完成签到,获得积分10
刚刚
u雨发布了新的文献求助10
1秒前
Voiceless的应助被Bin_Liu采纳,获得10
4秒前
不吃压力就是干完成签到 ,获得积分10
4秒前
Lingeek完成签到,获得积分10
9秒前
霸气芫完成签到 ,获得积分10
13秒前
13秒前
betty2009完成签到,获得积分10
14秒前
饱满千兰完成签到,获得积分10
15秒前
科研通AI6.3的应助被u雨采纳,获得10
19秒前
王kk完成签到 ,获得积分10
20秒前
哈哈哈完成签到 ,获得积分10
22秒前
邓代容完成签到 ,获得积分0
27秒前
奋斗诗云完成签到 ,获得积分10
29秒前
irisyan完成签到 ,获得积分10
31秒前
白云完成签到 ,获得积分10
32秒前
难过的研究牲完成签到 ,获得积分10
33秒前
大耳朵图图完成签到 ,获得积分10
34秒前
孤狼完成签到 ,获得积分10
38秒前
子良完成签到 ,获得积分10
38秒前
xinxin完成签到 ,获得积分10
39秒前
黑白完成签到 ,获得积分10
39秒前
一诺相许完成签到,获得积分10
41秒前
领导范儿的应助被文文采纳,获得10
43秒前
xh完成签到,获得积分10
44秒前
QwQ完成签到 ,获得积分10
45秒前
高兴的灰狼完成签到,获得积分20
45秒前
科研猫完成签到,获得积分10
46秒前
nanting完成签到 ,获得积分10
49秒前
momo完成签到,获得积分10
52秒前
求知小生完成签到 ,获得积分10
54秒前
Ava完成签到,获得积分10
55秒前
56秒前
冷傲的婷冉完成签到,获得积分10
58秒前
Ayun完成签到,获得积分10
58秒前
59秒前
Ayun发布了新的文献求助10
1分钟前
爱听歌的香萱完成签到,获得积分10
1分钟前
翰飞寰宇完成签到 ,获得积分10
1分钟前
wangji_2017发布了新的文献求助10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180068
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808724
捐赠科研通 7776054
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557425
邀请新用户注册赠送积分活动 2479012